Top Story

Infliximab desensitization reduces allergic reactions in patients with inflammatory bowel disease

July 1, 2015

Desensitization may be successful in limiting the severity of adverse reactions people with inflammatory bowel disease experience when using infliximab, according to study results.

“Most patients who developed reactions to infliximab benefited from desensitization and continued to receive their effective treatment without significant adverse effect,” Ahmad A. Mourad, MD, of the allergy and immunology section at Louisiana State University Health, and colleagues wrote.


BLOG: Health care providers need to consider options offered by patient financing programs

July 1, 2015
Most health care practices have financial policies in place that require payment by cash, check or major credit card for out-of-pocket costs. However, in today’s…
Medicare fraud takedown: A closer look Health Care Legislative and Regulatory Update

Medicare fraud takedown: A closer look

June 30, 2015
From international law firm Arnold & Porter LLP comes a timely column that provides views on current regulatory and legislative topics that weigh on the minds of…
FDA News

FDA designates oral immunotherapy as breakthrough for children with peanut allergy

June 30, 2015
Aimmune Therapeutics announced its lead investigational product, AR101, for oral immunotherapy of children and adolescents aged 4 to 17 years with peanut allergy has…
In the Journals

Classroom airborne endotoxin levels lead to increased asthma symptoms

June 30, 2015
Inner-city children with asthma are at risk for experiencing more asthma symptoms because of being exposed to high airborne endotoxin levels at school, according to…
More News Headlines »
Meeting News Coverage Video
thumbnail for video 4143327648001

Researcher looks at relationship between atopic dermatitis, obesity and cardiovascular disease

March 30, 2015
SAN FRANCISCO — In this video, Jonathan I. Silverberg, MD, PhD, MPH, discusses studies examining cardiovascular…
More »